Oppenheimer & Co’s Beyond Meat BYND Stock Holding History

Oppenheimer & Co’s Portfolio BYND Stock Details BYND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-211	Closed	-$825K	–	1516
2021 Q1	$825K	Sell	211 -156	-43%	-$688K	0.02%	772
2020 Q4	$1.38M	Buy	367 +97	+36%	+$439K	0.03%	544
2020 Q3	$1.35M	Buy	270 +64	+31%	+$260K	0.03%	483
2020 Q2	$828K	Sell	206 -17	-8%	-$60.4K	0.02%	647
2020 Q1	$444K	Buy	+223	New	+$649K	0.01%	774

Other funds holding BYND

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Oppenheimer & Co's BYND Position: Q2 2021 in Review

Oppenheimer & Co sold out of Beyond Meat (BYND) in Q2 2021, closing a stake of 211 shares — an estimated $825K sold.

Oppenheimer & Co first reported a position in BYND in Q1 2020 and held it in 5 quarters. The position peaked at $1.38M in Q4 2020. 438 funds tracked by Wall St. Rank hold BYND as of Q2 2021.

Oppenheimer & Co reported no remaining Beyond Meat position as of Q2 2021 after selling out during the quarter.
Oppenheimer & Co sold 211 Beyond Meat shares in Q2 2021, an estimated $825K.
Oppenheimer & Co first reported a position in Beyond Meat in Q1 2020 and held it in 5 quarters.
Oppenheimer & Co's Beyond Meat position peaked at $1.38M in Q4 2020.
438 funds tracked by Wall St. Rank held Beyond Meat as of Q2 2021.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.